BioSpace News Archive

Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that Andreas Johannesson has been appointed interim CFO, effective 5 March 2020.

Thermo Fisher Scientific today released five new Thermo Scientific SureTect PCR Assays and enhanced software to test food and related samples for:

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced the granting of inducement awards to three new employees.

Caregility, announces the organization will be exhibiting at the 2020 Healthcare Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition at the Orange County Convention Center in Orlando, Florida, March 9-13, 2020.

Sickweather, the world’s first crowdsourced real-time map of sickness, today issued a warning that there will be no respite from flu-like symptoms and respiratory illness in the spring and summer months – and is urging consumers to safeguard themselves against the ongoing spread of illness.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its fourth quarter and full year 2019 financial and operating results on Thursday, March 12, 2020, following the close of the U.S. financial markets.

Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced that it will give an oral presentation at the 2020 International Conference on Frailty and Sarcopenia (ICFSR) in Toulouse, France on March 12, 2020.

DermTech, Inc. (NASDAQ:DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that the Journal of Drugs and Dermatology has published the results of a large registry study confirming the clinical utility of the DermTech Pigmented Lesion Assay (the “DermTech PLA”).

Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced that the Company will report fourth quarter/year-end 2019 financial results and provide a business update on Thursday, March 12, 2020

Orionis Biosciences is today debuting with the announcement of a major drug discovery collaboration with Novartis.